OM-85

OM-85 or OM85 is an immunostimulant. It is a combination of molecules extracted from the walls of bacteria that commonly cause respiratory infections.[1]

Uses

It has been sold, as Broncho-Vaxom, in Europe and some South American countries.[1] It is used for children with asthma or recurrent respiratory infections.[1]

Potential uses

It may help prevent Covid-19.[2]

It may prevent babies from developing asthma.[3][4]

Composition

It is a mix of lipopolysaccharides,[4] extracted from bacteria cell walls.

Clinical trials

It has been studied in numerous pediatric clinical trials.[2]

References
  1. OM85: could bacteria in a capsule protect us from coronavirus and other respiratory infections?
  2. "Efficacy and safety of OM-85 in paediatric recurrent respiratory tract infections which could have a possible protective effect on COVID-19 pandemic: A meta-analysis". 22 Jan 2021. doi:10.1111/ijcp.13981. {{cite journal}}: Cite journal requires |journal= (help)
  3. Hart (15 Feb 2022). "Aussie researchers make asthma breakthrough".
  4. Troy (14 Feb 2022). "Protection against severe infant lower respiratory tract infections by immune training: Mechanistic studies". doi:10.1016/j.jaci.2022.01.001. {{cite journal}}: Cite journal requires |journal= (help)


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.